In this episode, Boston Scientific’s own Global Chief Medical Officer Ian Meredith sits down with Doctors Molly Szerlip and Vinod Thourani to discuss treating TAVR patients during the COVID-19 era. 
  
Chapter 1: Treating TAVR Patients Today (0:46) 
Chapter 2: Adapting TAVR Practices to Ensure Patient Safety (8:27) 
Chapter 3: Patient and Procedural Strategy (14:55) 
Chapter 4: The Heart Team in a Virtual World (22:45) 
Chapter 5: The Impact on Clinical Trial Research (26:08)

Chapter 2: Adapting TAVR Practices to Ensure Patient Safety

Chapter 3: Patient and Procedural Strategy

Chapter 4: The Heart Team in a Virtual World

Chapter 5: The Impact on Clinical Trial Research

Examining Cerebral Embolic Protection

A new podcast by Boston Scientific where peers discuss timely topics in the structural heart field.